| 1 | 1 | | II |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION S. 832 |
|---|
| 5 | 5 | | To amend title XI of the Social Security Act to equalize the negotiation |
|---|
| 6 | 6 | | period between small-molecule and biologic candidates under the Drug |
|---|
| 7 | 7 | | Price Negotiation Program. |
|---|
| 8 | 8 | | IN THE SENATE OF THE UNITED STATES |
|---|
| 9 | 9 | | MARCH4, 2025 |
|---|
| 10 | 10 | | Mr. T |
|---|
| 11 | 11 | | ILLIS(for himself, Mr. BUDD, Mrs. BLACKBURN, Mr. DAINES, and Mr. |
|---|
| 12 | 12 | | L |
|---|
| 13 | 13 | | ANKFORD) introduced the following bill; which was read twice and re- |
|---|
| 14 | 14 | | ferred to the Committee on Finance |
|---|
| 15 | 15 | | A BILL |
|---|
| 16 | 16 | | To amend title XI of the Social Security Act to equalize |
|---|
| 17 | 17 | | the negotiation period between small-molecule and bio- |
|---|
| 18 | 18 | | logic candidates under the Drug Price Negotiation Pro- |
|---|
| 19 | 19 | | gram. |
|---|
| 20 | 20 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 21 | 21 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 22 | 22 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 23 | 23 | | This Act may be cited as the ‘‘Ensuring Pathways 4 |
|---|
| 24 | 24 | | to Innovative Cures Act of 2025’’ or the ‘‘EPIC Act of 5 |
|---|
| 25 | 25 | | 2025’’. 6 |
|---|
| 26 | 26 | | VerDate Sep 11 2014 02:19 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S832.IS S832 |
|---|
| 27 | 27 | | kjohnson on DSK7ZCZBW3PROD with $$_JOB 2 |
|---|
| 28 | 28 | | •S 832 IS |
|---|
| 29 | 29 | | SEC. 2. EQUALIZING THE NEGOTIATION PERIOD BETWEEN 1 |
|---|
| 30 | 30 | | SMALL-MOLECULE AND BIOLOGIC CAN-2 |
|---|
| 31 | 31 | | DIDATES UNDER THE DRUG PRICE NEGOTIA-3 |
|---|
| 32 | 32 | | TION PROGRAM. 4 |
|---|
| 33 | 33 | | Section 1192(e)(1)(A)(ii) of the Social Security Act 5 |
|---|
| 34 | 34 | | (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended— 6 |
|---|
| 35 | 35 | | (1) by striking ‘‘year, at least 7’’ and inserting 7 |
|---|
| 36 | 36 | | ‘‘year— 8 |
|---|
| 37 | 37 | | ‘‘(I) for initial price applicability 9 |
|---|
| 38 | 38 | | years 2026 and 2027, at least 7’’; and 10 |
|---|
| 39 | 39 | | (2) by adding at the end the following: 11 |
|---|
| 40 | 40 | | ‘‘(II) for initial price applicability 12 |
|---|
| 41 | 41 | | year 2028 and each subsequent initial 13 |
|---|
| 42 | 42 | | price applicability year, at least 11 14 |
|---|
| 43 | 43 | | years will have elapsed since the date 15 |
|---|
| 44 | 44 | | of such approval; and’’. 16 |
|---|
| 45 | 45 | | Æ |
|---|
| 46 | 46 | | VerDate Sep 11 2014 02:19 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\S832.IS S832 |
|---|
| 47 | 47 | | kjohnson on DSK7ZCZBW3PROD with $$_JOB |
|---|